Transarterial chemoembolisation enhances programmed death-1 and programmed death ligand-1 expression in hepatocellular carcinoma

被引：0
|
作者：
Montasser, A. [1 ,2 ]
Beaufrere, A. [1 ,3 ]
Cauchy, F. [4 ]
Soubrane, O. [4 ]
Colnot, N. [1 ]
Tessiore, S. [1 ]
Albuquerque, M. [1 ,3 ]
Paradis, V. [1 ,3 ]
机构：
[1] Beaujon Univ Hosp, AP HP, Dept Pathol, Clichy, France
[2] Theodor Bilharz Res Inst, Dept Pathol, Giza, Egypt
[3] Beaujon Univ Hosp, INSERM, U1149, Clichy, France
[4] Beaujon Univ Hosp, AP HP, Dept HPB & Pancreat Surg, Clichy, France
来源：
VIRCHOWS ARCHIV | 2019年 / 475卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-05-004
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [1] Transarterial chemoembolisation enhances programmed death-1 and programmed death-ligand 1 expression in hepatocellular carcinoma
    Montasser, Ahmed
    Beaufrere, Aurelie
    Cauchy, Francois
    Bouattour, Mohamed
    Soubrane, Olivier
    Albuquerque, Miguel
    Paradis, Valerie
    [J]. HISTOPATHOLOGY, 2021, 79 (01) : 36 - 46
  • [2] Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma
    Yu Wei-Bo
    Rao Jian-Yu
    [J]. 慢性疾病与转化医学(英文), 2019, 5 (03) : 170 - 177
  • [3] Programmed death-1 and programmed death ligand-1 blockade for advanced urothelial carcinoma
    Guo, Jhe-Cyuan
    Tsai, Yu-Chieh
    Pu, Yeong-Shiau
    [J]. UROLOGICAL SCIENCE, 2019, 30 (01) : 2 - 7
  • [4] Expression of programmed death ligand-1 and programmed death 1 in hepatocellular carcinoma and its clinical significance
    Long, J.
    Qu, Tao
    Pan, X. F.
    Tang, X.
    Wan, H. H.
    Qiu, P.
    Xu, Yan-Hua
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S1188 - S1192
  • [5] Expression patterns of programmed death-1 and programmed death-1 ligand-1 on T cells in gastric cancer
    Kim, Ji-Hyun
    Kim, Shinn-Young
    Shin, Eun-Young
    Jung, Ji-Han
    Choi, Hyun-Joo
    Jun, Kyong-Hwa
    [J]. ONCOLOGY LETTERS, 2019, 18 (03) : 2661 - 2669
  • [6] Prognostic value of programmed death ligand-1 and programmed death-1 expression in patients with upper tract urothelial carcinoma
    Campedel, Luca
    Comperat, Eva
    Cancel-Tassin, Geraldine
    Varinot, Justine
    Pfister, Christian
    Delcourt, Clara
    Gobet, Francoise
    Roumiguie, Mathieu
    Patard, Pierre-Marie
    Daniel, Gwendoline
    Bigot, Pierre
    Carrouget, Julie
    Eymerit, Caroline
    Larre, Stephane
    Leon, Priscilla
    Durlach, Anne
    Ruffion, Alain
    de Mazancourt, Emilien Seizilles
    Decaussin-Petrucci, Myriam
    Bessede, Thomas
    Lebacle, Cedric
    Ferlicot, Sophie
    Robert, Gregoire
    Vuong, Nam-Son
    Philip, Magali
    Crouzet, Sebastien
    Matillon, Xavier
    Mege-Lechevallier, Florence
    Lang, Herve
    Mouracade, Pascal
    Lindner, Veronique
    Gougis, Paul
    Cussenot, Olivier
    Roupret, Morgan
    Seisen, Thomas
    [J]. BJU INTERNATIONAL, 2023, 132 (05) : 581 - 590
  • [7] Interaction of Programmed Death-1 and Programmed Death-1 Ligand-1 Contributes to Testicular Immune Privilege
    Cheng, Xuyang
    Dai, Hehua
    Wan, Ni
    Moore, Yolonda
    Vankayalapati, Ramakrishna
    Dai, Zhenhua
    [J]. TRANSPLANTATION, 2009, 87 (12) : 1778 - 1786
  • [8] Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer
    Ohigashi, Y
    Sho, M
    Yamada, Y
    Tsurui, Y
    Hamada, K
    Ikeda, N
    Mizuno, T
    Yoriki, R
    Kashizuka, H
    Yane, K
    Tsushima, F
    Otsuki, N
    Yagita, H
    Azuma, M
    Nakajima, Y
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (08) : 2947 - 2953
  • [9] Expression of programmed death ligand-1 and programmed death-1 in samples of invasive ductal carcinoma of the breast and its correlation with prognosis
    Zhou, Tingting
    Xu, Di
    Tang, Bufu
    Ren, Yanling
    Han, Yiru
    Liang, Gege
    Wang, Jing
    Wang, Ling
    [J]. ANTI-CANCER DRUGS, 2018, 29 (09) : 904 - 910
  • [10] Interferons induce programmed death-1 ligand-1 expression in hepatocytes
    Miihlbauer, M
    Fleck, M
    Weiss, T
    Froh, M
    Hoves, S
    Schölmerich, J
    Hellerbrand, C
    [J]. HEPATOLOGY, 2005, 42 (04) : 571A - 571A
12345